$1.60
-0.01 (-0.62%)
TENX News2 articles
Tenax Surges 28% on $1.81M Insider Buy Ahead of Trial Data
Tenax shares surged 27.84% to $2.37 after a director bought $1.81M of stock. Investors await further LEVEL trial data on August 29.
Tenax Therapeutics Plunges 85% as Phase 3 Trial Misses Key Goals
Tenax Therapeutics (TENX) shares plummeted 85% premarket after its Phase 3 LEVEL trial failed to meet primary endpoints, erasing $425 million in market cap.